Neoadjuvant Chemo May Improve Outcomes for MIBC of Variant Histology
Findings refute the notion that variant histology MIBC will not respond to neoadjuvant chemotherapy.
All articles by Natasha Persaud
Kidney-Sparing Surgery Offers Effective Oncologic Control in High-Risk UTUC
In this small study, even patients with high-risk tumors appeared to benefit from nephron-sparing surgery.
Epigenetic Test May Rule Out High-Grade UTUC
If validated, the EpiCheck® assay may identify more patients who can safely delay or avoid nephroureterectomy.
Neoadjuvant Chemotherapy Underused for MIBC in Older Adults
Older age independently predicted significant 48% lower odds of the gold standard treatment of NAC and radical cystectomy.
Nadofaragene Firadenovec Shows Longer-Term Efficacy in BCG-Unresponsive NMIBC
Study results support an attempt at bladder preservation in patients with BCG-unresponsive nonmuscle-invasive bladder cancer.
Investigators: Consider 5-ARI Use When Deciding on Prostate Biopsy
At prostate cancer diagnosis, clinical T stage was significantly higher among 5-ARI users compared with nonusers.
Outcomes of BCG-Unresponsive NMIBC Characterized
In a small study, most BCG-unresponsive patients who were initially managed conservatively ultimately underwent cystectomy.
Study: Delaying ADT for Recurrent Prostate Cancer May Not Worsen Survival
Investigators question initiation of continuous androgen deprivation therapy (ADT) for biochemically recurrent prostate cancer without metastasis.
FDA Okays COVID-19 Vaccine Booster Shot for Immunocompromised Patients
An appropriate vaccination strategy will follow.
Positive Margins After Partial Nephrectomy Predict Worse Oncologic Outcomes
Decisions of how to proceed when positive surgical margins are found after partial nephrectomy are left to the discretion of the surgeon.
- Loading...
Loading...
Next post in Renal Cell Carcinoma
Loading... 
Loading...